This combination therapy has shown considerable efficacy in remodeling the tumor TME by reducing tumor-infiltrating immune cells such as Tregs and MDSCs while decreasing cytokines like IL-6, TGF-β, and TNF-α. The gene discussed is TNF; the disease is neoplasm.